| Literature DB >> 29963376 |
Vincent Chauvette1, Amine Mazine2, Denis Bouchard3.
Abstract
Aortic stenosis has traditionally been addressed with surgical aortic valve replacement (AVR). In recent years, several technologies have emerged as alternative treatment methods for aortic valve disease. Among them, the Perceval (LivaNova, London, UK) is a sutureless valve that has been used in clinical practice for over 10 years. It has been implanted in over 20,000 patients worldwide. With nearly 600 Perceval implants since 2011, the Montreal Heart Institute has developed a worldwide expertise with this technology. In this article, we provide an overview of the clinical data currently available in the literature and discuss the lessons we have learned from our experience with the Perceval prosthesis.Entities:
Keywords: Perceval S prosthesis; Sutureless valves; aortic valve replacement (AVR)
Year: 2018 PMID: 29963376 PMCID: PMC5994436 DOI: 10.21037/jovs.2018.03.10
Source DB: PubMed Journal: J Vis Surg ISSN: 2221-2965